Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- H.RES.449
H.RES.449: Relating to breast implants, the Food and Drug Administration, and breast care.
About This Bill
- This bill was introduced in the 104th Congress
- This bill is primarily about education
- Introduced June 6, 1996
- Latest Major Action June 14, 1996
Bill Sponsor
Bill Cosponsors
20 (8 Democrats, 12 Republicans)
Bill Summary
Expresses the sense of the House of Representatives that: (1) the Food and Drug Administration should issue a definitive statement on the relationship (or lack thereof) between silicone gel breast implants and connective tissue disease, classic auto-immune symptoms, and other serious diseases; and (2) the Food and Drug Administration and the National Cancer Institute should develop recommendations for breast care for women with breast implants.
(Source: Library of Congress)
Bill Actions
| Date | Description |
|---|---|
|
Referred to the House Committee on Commerce.
|
|
|
Sponsor introductory remarks on measure.
|
|
|
Referred to the Subcommittee on Health and Environment.
|
|
| June 6, 1996 |
Introduced in the House by Barbara Farrell Vucanovich (R-Nev.) |